News and Events

PI3Kα(H1047R) inhibitors were designed to target a specific mutation that plays a key role in certain cancers, particularly breast cancer. Click the link to explore what we have for you.

We are happy to present the first result of our collaboration with NexMR – Photoinducible Fragment Library! Read more here.

Uliana Matviienko and Aliona Savitch send best wishes from SLAS 2024 in Barcelona!

We are delighted to continue our series in Molecule Builder!
 
Tovorafenib, also known by the brand name Ojemda®, is an oral medication classified as a type II RAF inhibitor.

Meet us at SLAS 2024 in Barcelona! From May 27th to May 29th, chat with Uliana Matviienko, our Supply Chain Director, and Aliona Savitch, Product Owner. See you there!

Happy National Vyshyvanka Day! Let each stitch in your vyshyvanka be a symbol of our cultural heritage and unity. Wishing you joy with loved ones and endless inspiration! Thank you for staying with us and Ukraine. 

Until July 31, we offer up to 50%-off discounted prices for the list of small molecules by TargetMol. Read more here.

We continue our "Meet Chemspace Team" post series! Introducing our senior account manager, Alina Kolosovska! Click the link to discover more about her.

Discover key analog molecules for fragments of a potential drug such as CRN04894, a promising treatment for Cushing syndrome in the last issue of the "Building Blocks for Drug Candidates" series. Find them here.

We are summarizing the latest updates from Chemspace. Check out our April post roundup!

In March, the FDA approved Danicopan (Voydeya®) for treating chronic, progressive and potentially life-threatening blood disorder. This drug's backbone includes a 3-fluoropyrrolidine moiety. Explore 3-fluoropyrrolidine-based compounds for your research! 

Growing fragments into lead compounds has never been simpler with our REAL Fragment Pre-Plated Library! Learn more here.

With the release of ChEMBL 34, we are thrilled to announce that our ChEMBL analogs collection has been updated as well! Click here to discover our ChEMBL analogs.

Our latest webinar with AlphaMa on 'Intelligent application of DNA-encoded libraries' is now live on the Chemspace YouTube channel!

We bring you a new post in our series inspired by Drug Hunter's "Molecules of the Month"!

A recently highlighted molecule is AZD5462 - a therapeutic candidate recently identified by Drug Hunter, which is a powerful and specific pharmacological mimic of relaxin H2 signaling that could be used to treat heart failure.

Meet Rita Gaidar at the 35th Symposium on Medicinal Chemistry in Eastern England on April 25th. Looking forward to exploring partnership opportunities!

Do not miss a chance to join our webinar, which will take place tomorrow at 3 pm CET | 9 am EDT | 9 pm CST (Beijing time)! Register via the link.

Explore a selected Biological Products Set from Chemspace for studying Methionine adenosyltransferase 2A (MAT2A) pathways, crucial in different kinds of cancer. Follow the link to check out the comprehensive selection at Chemspace Biologics! 

Check out our new series: "Building Blocks for Drug Candidates"! Discover essential sets for synthesizing potential drugs like Cilofexor, a promising treatment for primary sclerosing cholangitis.

Join our webinar “Intelligent Applications of DNA-Encoded Chemical Libraries”, which will take place at 3 pm CET on April 18th, 2024. 

Meet Chemspace team at EFMC-ASCMEDI Medicinal Chemical Frontiers 2024, taking place from April 8-11 in Utrecht, the Netherlands. 

We are summarizing the latest updates from Chemspace. Check out our March post roundup!

Meet our new product – REAL Fragment Library! Discover the new efficient method of fragment growing inside Enamine REAL space.

Today we would like you to meet our Junior Backend Developer - Dmytro Yehorov. Follow the link to get to know him better!

Check out our latest featured article where researchers utilized the next generation SpaceProp2 analysis tool to explore Freedom Space.